PCSK9 and malignant colon neoplasm: Indeed, a previous animal study demonstrated that PCSK9 inhibition using the nano-liposomal anti-PCSK9 vaccine had a moderately inhibitory activity in tumor growth and improved the lifespan and survival of the mice, thus providing support for the potential use of PCSK9 inhibitors in the treatment of colon cancer [53].